Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Men in the U.S. have more health issues, higher death rates from various diseases, lower life expectancy, and are less likely to seek healthcare.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Most people in Alahsa, Saudi Arabia, have low awareness of thyroid disease symptoms and risk factors.

TSH is usually the only test needed to check thyroid function in primary care.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Physical activity, height, and smoking affect prostate cancer risk.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Key genes linked to hair growth and cancer were identified in hairless mice.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.